| BACKG ROU N D
Patients, carers and members of the public are increasingly recognized as playing or as having the potential to play an important role in improving health services. This can include leading and developing innovative solutions to problems that matter to them. However, little is known about the roles played by patients, or the mechanisms by which patients can develop and diffuse local innovations in a complex health-care system. Patient developed innovations rarely spread beyond their own personal use.
Oliveira et al 1 suggest that when patients develop innovations, these are mostly used to help themselves, or those they care directly for, but are rarely shared more widely. They surveyed 500 patients who had rare diseases to measure how many had developed innovations to help themselves and/or support their own care. They found that 8% of the total number of patients who responded to the survey had developed innovative solutions for themselves that medical experts evaluated as novel. The majority of the innovations focused on increasing the patient's autonomy and quality of life. Lack of diffusion of patient innovation was due to significant barriers to doing so, including inventors' lack of time, skills and opportunities to develop their innovations, and lack of contact with communities who are likely to use the innovation. One of the conclusions of their study was that patients have the potential to transform health care but for that to happen they need to be supported and their input integrated into health-care delivery.
Denis et al 2 theorize that the dissemination of innovations is not necessarily a linear process which adheres to a plan, and that the process of diffusion can be discerned as an interaction between the innovation with its key characteristics and an adopting system, composed of actors with a set of values, interests and power de- Key limitations of diffusion theories have been noted 2,4,5 among which are: it is extremely difficult to account for all the factors which might have played a part in diffusion, and that diffusion theories cannot account for all variables which are likely to be responsible. Most models of diffusion are presented as linear, when the reality is that there is often overlap between the different drivers of and motivations for it.
Patients as innovators in NHS or other health-care settings are written about in policy, empirical and theoretical studies. Insights into patient roles in relation to developing, disseminating or diffusing innovations are rarely mentioned. Instead, the focus is on how patients can be, or are involved in health-care planning, delivery, evaluation and research. Evidence of patients and carers influencing and successfully co-producing service improvement is increasingly studied. Authors have noted that co-production can enhance patient and clinician experience and patient and service outcomes, even though patients' experience and expertise are often not used to the fullest. [6] [7] [8] [9] [10] [11] The positive impact that patient engagement and involvement in health care can have on outcomes, including improving patients' understanding of their health conditions, how these can be treated and managed, self-management and peer-to-peer learning, is noted in empirical and policy-focused studies. 12, 13 Patients are increasingly taking on roles in setting research agendas, including suggesting research questions, becoming part of a research team was important. Principles described in this study are relevant to progressing other patient-led ideas for innovative changes relating to health service development.
K E Y W O R D S
case study, co-production, diffusion, health care, infrastructure support, innovation, patient's roles, self-care and evaluating outcomes. [14] [15] [16] Commentators, however, suggest that the potential for patients to participate in research continues to be underutilized. [17] [18] [19] Patients' participation in self-care and their potential to play important roles in enhancing the learning of their doctors is thought to be driving a scientific paradigm change in which the patient's voice is central to an emerging era of participatory medicine. 20 In addition, guidelines for how, when and why to involve patients are increasingly published by patient-led, third sector groups and used in NHS settings. 21, 22 This literature provides a lens through which we can understand the landscape in which patients have played important roles. 
| DE S I G N

| Data collection
We accessed a database used to record how many orders for the MMP innovation were fulfilled, where in the country those orders were sent, and who they were sent to. Between 5 April 2013 and 31
September 2017, 164 000 were ordered.
We accessed n = 51 documents. These were related to the diffusion of the innovation after it had been developed, tested and implemented on five health-care sites in Northwest London. See Table 1 .
| Data analysis
From the electronic order database, we analysed how many MMPs were ordered and the extent of diffusion from 5 April 2013 to 30
September 2017. An analysis of the database using an Excel spreadsheet enabled us to understand who had ordered the innovation, their occupation and where in the UK they were based. The database was analysed using geographical information system software, and post-code analysis conducted, which was mapped to a visual output (Figures 2 and 3 ).
From the 51 documents, we compiled a timeline giving an overview of the development through to the diffusion of MMP.
See Figure 1 . From documents relating to the work of the steering group, which was convened to make the MMP innovation available to anyone who would like to use it, the roles of patients in planning and raising awareness about the transition from dissemination to diffusion of the MMP were noted. Roles played by patients are summarized in Table 2 , types of events they coproduced in Table 3 , and audiences who attended the events in Table 4 .
We purposively identified three tracer cases which we pres- 
| Limitations
This study had four key limitations. First, it was impossible to collect comprehensive data about all the roles played by all the patients and health-care professionals involved in the diffusion process. The study focuses mostly on patient's and carer's roles because there
TA B L E 1 Documents and other sources accessed
Type of document Number
Records of steering group meetings to make MMP available nationally 12
Grey literature/newsletters containing articles about MMP 11
Presentations used in awareness-raising events and workshops 9
Posters shown at conferences 6
Vignettes showing records of how MMP was used/diffused-collected from records including email correspondence, websites, firsthand reports by users 
| RE SULTS
| Geographical spread and diffusion of the MMP innovation
The timeline presented in Figure 1 starts with the development of the MMP innovation which was initially part of a service improvement project in Northwest London. The timeline shows the trajectory of progress to diffusion. Other occupations of those placing orders were categorized: administrative worker; care centre worker; charity, community interest or third sector worker; clinician (secondary care); GP or primary care practice staff; health-care assistant; health service commissioning and related occupations; nurse; occupational therapist; physiotherapist; research.
| Launch of MMP outside Northwest London
During 2012-13, a steering group convened to "develop and implement a strategy for the roll-out of 'My Medication Passport' live with learning disabilities. They gave presentations about their experience of using MMP, the value it could provide for others and how to use it. They kept a record of the events that they and other steering group members attended which were linked to the strategy (n = 74) and they presented progress reports to the steering group.
TA B L E 2 Roles played by patients in communication events
Many, but not all the events were held in Northwest London. 
| Professional networks
A key principle of the steering group's strategic communication plan was to raise awareness of MMP and encourage community and hospital-based pharmacists to support it. Pharmacists who were members of the steering group were based in hospitals in Northwest London. They were able to use established hospital-based networks to further disseminate the MMP.
However, they had to establish contact with community-based networks. Action taken was multifaceted. Pharmacists and patients worked together to co-produce posters which were presented at in a variety of settings, in hospitals, local and national conferences and meetings. Pharmacists, carers and patients co-created training materials containing advice on how MMP could be used. These were used in workshops and appeared on websites and in newsletters. 35 The content of face-to-face training was co-developed and delivered by pharmacists and patients. Patients volunteered in high street chemists, raising awareness about MMP. New relationships were built between pharmacists who were members of the steering group and other pharmacists, and between patients and pharmacists, and advocacy opportunities taken advantage of. Orders for MMP started to be placed. Figure 2 demonstrates the growth in orders placed for MMP in Northwest London from 2013. Figure 3 shows the growth in orders across the UK, and that the largest number of orders was placed by pharmacists.
| Role of a carer: linking to new networks
A member of the steering group, a carer, who is a co-author of 
| Vignette 1. Patient participation group-GP practice and local community
This is a summary of a direct transcription from the Chair of a Patient Participation Group (PPG) for a medical centre in the North of England, who had heard about MMP from a patient network.
The GP surgery that the PPG supported had recently made patient access to their medical records freely available. It was found that not all patients wanted to access their records online, and not all had computers or access to the Internet. The Chair heard about MMP, and on consulting with GPs, and the PPG, it was decided that MMP could help support the needs of patients who preferred to carry information with them to health-care appointments, or to show a friend or neighbour who would potentially support them if needed. She observed:
The PPG and GPs are keen to provide the best service for patients who can't or don't want to use online services, and I thought the MMP was a great solution.
I sent off for some passports and we started asking patients what they thought about them. Everybody thought they were great and the typical response was "Can I have another for my mum, husband, sister?"
The PPG worked with doctors and staff at the medical centres and it was agreed to offer patient's MMP to enable them to keep their own records, check these with their online record if they wanted to, and to use it as they wished.
The pharmacy based at the medical centre puts MMP into the prescription bags for patients with multiple medicines. Iterative feedback showed that patients and carers valued MMP and had ideas about other potential users with a known need for it. One carer said that when he took his wife in an ambulance, he took MMP with him and gave it to the consultant, who had welcomed it and said that "every patient should have one."
In planning how best to support patients in the local area, the PPG considered patients they realized might benefit most from using the innovation and planned some outreach activities designed to bring MMP to their attention. For example, they supported the establishment of the use of the innovation in the local nursing home and via a local retirement housing scheme. A volunteer driver for nursing home resident's transport reported that he had been aware and worried that patients had no information with them about their medicines and no carer to listen or be their advocate during emergency and/or regular health-care appointments.
He became an advocate of the innovation and reported that patients used it.
The PPG made the innovation available to local community groups and they set up a stall in the local shopping centre. They had members who made it available to the local over 60s choir and facilitated their use of it.
The PPG was active in national networks and promoted the use of 
| Vignette 2. Advocates for patients who live with learning disabilities
This vignette is based on publications highlighting the role and experiences that one person who described himself as "carer, parent, patient and health-care professional (pharmacist)" and the influence he had on others. He was an advocate for the use of the innovation and he published a case study about his own use of MMP to support the care of his son who has multiple disabilities including a learning disability. 27 By publishing the case study and outlining the context in which the innovation was useful and through the publication of an additional article written for a broader audience with learning disabilities, 36 at least two different sorts of peer community were influenced via peer and third sector networks. 
| Vignette 3. Promotion of MMP across social and professional networks
This vignette is a compilation of some brief examples of how the MMP innovation diffused though the networks of patients, carers and health-care professionals.
A sports club for older people advocated the use of and disseminated MMP to its members after a man, one of its players, collapsed whilst playing cricket and required hospitalization. Friends of the man knew that he took multiple medicines but not which ones. They quickly became aware of how difficult it was for a hospital to secure any information that could confirm which medicines the man took, as both GP and community pharmacists were not open, and they recognized that the man lacked close family or friends who might have been able to help.
A local pharmacy group invited pharmacists who had experience of using MMP to their network events to explain how and why MMP had been developed, and to raise awareness about the potential benefits to pharmacists and to patients of using it. Several similar events led to training workshops being organized for pharmacists, and a training package aimed at their use of the innovation was developed and used.
A further example of the MMP innovation diffusion occurred between a hospital and patients who participated in a local PPG.
Patients and carers used the innovation in the community. They discussed its potential to be of use to patients who used the local hospital pharmacy. That pharmacy went on to regularly order the innovation and to offer it to patients who took multiple medicines.
A health service network of staff and patients, and a community interest company that supports the diffusion of good practice relating to prescribing and supported NHS commissioners highlighted the MMP innovation in publicity and on their websites. They advocated the use of the innovation by patients, pharmacists and other prescribers to aid good practice.
39,40
| D ISCUSS I ON AND CON CLUS I ON S
The authors' reflections on the findings are that patients played important roles in the diffusion of innovations shaping health service organization and delivery. These were as follows: advocate; relationship builder; relationship broker; planner; presenter; awareness raiser; trainer; networker; co-producer. Patients identified and introduced potential audiences and users to MMP, using social, organizational, sectoral, lay and professional networks to do so. They navigating organizational culture to good advantage; and the ability to use evidence to influence others. 23 They used their inter-personal and inter-organizational networks, with some of the original innovators going on to become champions and leading efforts to achieve diffusion, for example within the police and prison service, in third sector organizations such as the sports club mentioned in vignette 3, and via ethnic minority health networks, community-based groups as well as in libraries. 24 The roles that patients and carers played, and their personal qualities were not unique to them. However, we draw attention to this because the roles and qualities are under-recognized and overlooked in the literature as being linked to patients who influence change. In addition, the personal quality of empathy drove patients and carers to become advocates for others, influencing the use and diffusion of MMP.
Decisions about how to make the innovation available outside the setting and context in which it had been developed required strategic planning and corresponding action. Patients contributed to plans which they co-created with others. The roles they played drew on their lived experience as patients and from other aspects of their lives as workers and carers; their insights, skills and personal qualities. They contributed to planning events to publicize the innovation:
identified target audiences and potential users of it; created publicity material; developed key messages targeted to different audiences; decided target audiences and how to raise awareness among them; built relationships with them and supported the innovation's initial use in different settings. The timing, the resources required to support the activities and the necessary logistics to operationalize them were planned by patients for some audiences and by health- All examples required experimentation, collaboration and trust between patients, carers and health-care professionals in a common endeavour to spread knowledge about and encourage the use of the innovation. These factors underpinned new ways of working such as co-production, an approach described by Green et al in the context of health service improvement projects. 10 Filipe et al considered the concept of co-production recognizing that "such a process involves dialogue and recognition of each other's capabilities and knowledge," and this type of dialogue and recognition was evident in this study. 41 Learning was shared between patients and health-care
professionals. This echoes deBronkart, who observed that attitudes towards knowledge and skills evolve and change when patients and health-care professionals work together in mutual recognition that each can utilize their own experience and knowledge to improve care and support each other's learning. 20 Strategic use of networks by patients points to several roles that can be played by patients and carers. In vignette 1, the PPG brought together local patients, carers and organizations, raised awareness and supported the use of MMP locally. They presented their experience at a national network conference influencing and supporting other PPGs. Parents and advocates for the innovation described in vignette 2 made connections between their own life-experiences and those of others with whom they empathized. They influenced the strategy developed by the paediatric department of a hospital.
In vignette 3, the coach of the sports club acted strategically, making the innovation available to all members of the club who took medicines, and the pharmacist who was also a carer advocated for disabled people and influenced awareness about MMP via a national third sector network. At the heart of these actions can be seen an ability to act strategically, use networks and the motivation to increase self-care, self-advocacy and patient safety.
Patients involved in the NIHR CLAHRC NWL steering group described in this case study had professional support from clinicians, patient and public involvement specialists and managers working in health services and third sector organizations. This necessary and supportive environment helped to enable the diffusion of the MMP innovation and effectively realize the value of patient involvement.
The need for this support has been noted previously. [29] [30] [31] Patients and carers described in this study had the benefit of organizational infrastructure, enabling them to co-design, plan and work together with health-care professionals on a variety of activities which helped diffuse the MMP innovation. show that in addition patients can become change agents, helping put innovations into practice.
As opportunities to raise awareness and increase the use of the innovation snowballed, so MMP diffused. Without a driving strategy, Table 3 and audiences summarized in Table 4 reported that they had not had any previous contact with homeless people, or with some faith groups before building relationships with them to offer, demonstrate and advocate the use of MMP. Opportunities opened up for patients and health-care professionals to access previously untapped audiences. Along with Margaret Turley, a co-author of this paper, and other early users of the innovation, a vision for its diffusion was shared, tested, reshaped, developed and utilized by multiple others, as this paper shows. We would also like to thank Barry Jubraj for his useful comments on an early draft of this paper and Neil Stillman for his help with references and for a careful reading of the paper before submission.
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